U.S. RETRACTABLE NEEDLE SAFETY SYRINGES MARKET ANALYSIS

Leading Companies

Increasing research and development activities by key players are expected to drive the market growth over the forecast period. For instance, in July 2022, Sharps Technology, a U.S.-based medical device manufacturer, acquired Safeguard Medical’s smart syringe manufacturing facility for US$ 2.5 million. The acquisition aims to expand Sharps Technology’ manufacturing capabilities to address the increasing demand for smart syringes. Safeguard Medical is a U.S.-based manufacturer of smart syringes and emergency medical technologies.

• Retractable Technologies Inc., a company offers safety syringes featuring automated retraction technology, reported total net sales of US$44.7 million with an operating profit of US$9.7 million for the same time in 2018, compared to total net sales of US$11.0 million with an operating loss of US$ 2.7 million for the first quarter of 2023.
• On February 16, 2023, Zephyrus Innovations (Zephyrus), a medical device company, announced that it has received its first product 510(k) Marketing Approval from the U.S. Food and Drug Administration (FDA) for its Aeroject 3ml safety syringe. Zephyrus Aeroject is a single-use auto-retractable syringe developed for easy one-handed injection.

U.S. Retractable Needle Safety Syringes Market - Key Players

The major players operating in the U.S retractable needle safety syringes market include Becton, Dickinson and Company, Smiths Medical, Revolutions Medical Corporation, Retractable Technologies Inc., SOL-MILLENNIUM, Axel Bio Corporation, Inc., DMC Medical Limited, Medicina, Duopross Meditech Corp., and MHC Medical Products, LLC.